Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Continuation Trial for Patients Completing Study M02-518 and M02-570 of the Human Anti-TNF Monoclonal Antibody Adalimumab (D2E7) in Patients With Moderate to Severely Active Psoriatic Arthritis

NCT00195689 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00195689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00195689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Continuation Trial for Patients Completing Study M02-518 and M02-570 of the Human Anti-TNF Monoclonal Antibody Adalimumab (D2E7) in Patients With Moderate to Severely Active Psoriatic Arthritis
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2003
Completion date
Not reported
Enrollment
400
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis